Malaria Diagnostics Market Size to Reach USD 795 Million by 2032 | Growth Trends & Forecasts According to a newly published market research report by 24LifeSciences, global malaria diagnostics market is valued at USD 672 million in 2026 and is projected to reach USD 795 million by 2034, growing at a compound annual growth rate (CAGR) of 2.8% during the forecast period. Malaria diagnostics, which encompasses a suite of tests including Rapid Diagnostic Tests (RDTs), molecular diagnostics (PCR), and microscopy, are fundamental for the accurate and timely detection of Plasmodium parasites. These tools are critical for initiating appropriate treatment, preventing severe complications, reducing transmission, and supporting global malaria elimination efforts. Their established efficacy in both high-transmission and low-transmission settings continues to underpin their indispensable role in public health programs and clinical practice worldwide. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9428/malaria-diagnostics-market

Personalized Medicine Trends in the Ophthalmic Therapeutics & Drug Market According to a newly published market research report by 24LifeSciences, global ophthalmic therapeutics & drug market was valued at USD 33.92 billion in 2024 and is projected to reach USD 51.2 billion by 2032, growing at a compound annual growth rate (CAGR) of 5.1% during the forecast period 2025–2032. Ophthalmic therapeutics and drugs are specialized pharmaceutical products designed to treat a wide spectrum of eye diseases and disorders. These critical medications are formulated for topical administration, such as eye drops and ointments, or for invasive procedures like intravitreal injections, targeting conditions from common ailments like dry eye and allergies to serious, vision-threatening diseases such as age-related macular degeneration (AMD), glaucoma, and diabetic retinopathy. Key therapeutic classes include anti-allergy, anti-VEGF agents, anti-inflammatory, and anti-glaucoma medications. Their established efficacy in preserving vision and managing ocular health continues to underpin their critical importance in both clinical ophthalmology and global public health initiatives. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9401/ophthalmic-therapeutics-drug-market

Meningitis Diagnosis and Treatment Market Size to Reach USD 5.12 Billion by 2032 | Key Trends & Forecasts Global meningitis diagnosis and treatment market is undergoing a pivotal transformation driven by heightened infectious disease vigilance, rapid adoption of molecular diagnostics, and expanding access to emergency clinical care. Valued at USD 3.02 billion in 2024, the market is projected to rise to USD 3.26 billion in 2025 and further reach USD 5.12 billion by 2032, growing at a CAGR of 6.8%. This reflects the global push toward faster pathogen detection, improved treatment regimens, and stronger public health infrastructure. Access the complete dataset, competitive insights, and expert forecasts at 24LifeSciences. https://www.24lifesciences.com/meningitis-diagnosis-and-treatment-market-9528

Pyrethroid Market Shows Steady Growth, Driven by Agricultural Demand and Public Health Initiatives Pyrethroid market, a cornerstone of modern crop protection and public health, demonstrated solid foundations with a valuation of USD 2.15 billion in 2024. The market is projected to grow from USD 2.23 billion in 2025 to reach USD 3.12 billion by 2032, advancing at a compound annual growth rate (CAGR) of 4.3%. Access Full Market Intelligence: https://www.24chemicalresearch.com/reports/263766/global-pyrethroid-market